Safety and immunogenicity of IMVAMUNE, a promising candidate as a third generation smallpox vaccine.
Vollmar J, Arndtz N, Eckl KM, Thomsen T, Petzold B, Mateo L, Schlereth B, Handley A, King L, Hülsemann V, Tzatzaris M, Merkl K, Wulff N, Chaplin P.
Vollmar J, et al.
Vaccine. 2006 Mar 15;24(12):2065-70. doi: 10.1016/j.vaccine.2005.11.022. Epub 2005 Nov 28.
Vaccine. 2006.
PMID: 16337719
Clinical Trial.